205 related articles for article (PubMed ID: 27776672)
1. A Review of Methamphetamine Dependence and Withdrawal Treatment: A Focus on Anxiety Outcomes.
Hellem TL
J Subst Abuse Treat; 2016 Dec; 71():16-22. PubMed ID: 27776672
[TBL] [Abstract][Full Text] [Related]
2. A review of treatment options for co-occurring methamphetamine use disorders and depression.
Hellem TL; Lundberg KJ; Renshaw PF
J Addict Nurs; 2015; 26(1):14-23; quiz E1. PubMed ID: 25761159
[TBL] [Abstract][Full Text] [Related]
3. Putting the call out for more research: the poor evidence base for treating methamphetamine withdrawal.
Pennay AE; Lee NK
Drug Alcohol Rev; 2011 Mar; 30(2):216-22. PubMed ID: 21355922
[TBL] [Abstract][Full Text] [Related]
4. Targeting Withdrawal Symptoms in Men Addicted to Methamphetamine With Transcranial Magnetic Stimulation: A Randomized Clinical Trial.
Liang Y; Wang L; Yuan TF
JAMA Psychiatry; 2018 Nov; 75(11):1199-1201. PubMed ID: 30208372
[TBL] [Abstract][Full Text] [Related]
5. Clinical effects and management of methamphetamine abuse.
Romanelli F; Smith KM
Pharmacotherapy; 2006 Aug; 26(8):1148-56. PubMed ID: 16863490
[TBL] [Abstract][Full Text] [Related]
6. Feasibility and acceptability of approach bias modification during methamphetamine withdrawal and related methamphetamine use outcomes.
Manning V; Garfield JBB; Mroz K; Campbell SC; Piercy H; Staiger PK; Lum JAG; Lubman DI; Verdejo-Garcia A
J Subst Abuse Treat; 2019 Nov; 106():12-18. PubMed ID: 31540606
[TBL] [Abstract][Full Text] [Related]
7. A placebo-controlled trial of mirtazapine for the management of methamphetamine withdrawal.
Cruickshank CC; Montebello ME; Dyer KR; Quigley A; Blaszczyk J; Tomkins S; Shand D
Drug Alcohol Rev; 2008 May; 27(3):326-33. PubMed ID: 18368615
[TBL] [Abstract][Full Text] [Related]
8. Barriers to methamphetamine withdrawal treatment in Australia: findings from a survey of AOD service providers.
Pennay AE; Lee NK
Drug Alcohol Rev; 2009 Nov; 28(6):636-40. PubMed ID: 19930017
[TBL] [Abstract][Full Text] [Related]
9. Randomized controlled trial of dexamphetamine maintenance for the treatment of methamphetamine dependence.
Longo M; Wickes W; Smout M; Harrison S; Cahill S; White JM
Addiction; 2010 Jan; 105(1):146-54. PubMed ID: 19839966
[TBL] [Abstract][Full Text] [Related]
10. A review of the clinical pharmacology of methamphetamine.
Cruickshank CC; Dyer KR
Addiction; 2009 Jul; 104(7):1085-99. PubMed ID: 19426289
[TBL] [Abstract][Full Text] [Related]
11. Anxiety level and correlates in methamphetamine-dependent patients during acute withdrawal.
Su H; Zhang J; Ren W; Xie Y; Tao J; Zhang X; He J
Medicine (Baltimore); 2017 Apr; 96(15):e6434. PubMed ID: 28403074
[TBL] [Abstract][Full Text] [Related]
12. Identifying methamphetamine users at risk for major depressive disorder: findings from the methamphetamine treatment project at three-year follow-up.
Glasner-Edwards S; Mooney LJ; Marinelli-Casey P; Hillhouse M; Ang A; Rawson R;
Am J Addict; 2008; 17(2):99-102. PubMed ID: 18393051
[TBL] [Abstract][Full Text] [Related]
13. Psychiatric comorbidity of methamphetamine dependence in a forensic sample.
Kalechstein AD; Newton TF; Longshore D; Anglin MD; van Gorp WG; Gawin FH
J Neuropsychiatry Clin Neurosci; 2000; 12(4):480-4. PubMed ID: 11083165
[TBL] [Abstract][Full Text] [Related]
14. Effect of the environmental enrichment on the severity of psychological dependence and voluntary methamphetamine consumption in methamphetamine withdrawn rats.
Hajheidari S; Miladi-Gorji H; Bigdeli I
Neurosci Lett; 2015 Jan; 584():151-5. PubMed ID: 25459292
[TBL] [Abstract][Full Text] [Related]
15. Effects of environmental enrichment during induction of methamphetamine dependence on the behavioral withdrawal symptoms in rats.
Hajheidari S; Miladi-Gorji H; Bigdeli I
Neurosci Lett; 2015 Sep; 605():39-43. PubMed ID: 26275348
[TBL] [Abstract][Full Text] [Related]
16. A pilot randomised controlled trial of modafinil during acute methamphetamine withdrawal: feasibility, tolerability and clinical outcomes.
Lee N; Pennay A; Hester R; McKetin R; Nielsen S; Ferris J
Drug Alcohol Rev; 2013 Jan; 32(1):88-95. PubMed ID: 22630616
[TBL] [Abstract][Full Text] [Related]
17. The Impact of Exercise On Depression and Anxiety Symptoms Among Abstinent Methamphetamine-Dependent Individuals in A Residential Treatment Setting.
Rawson RA; Chudzynski J; Gonzales R; Mooney L; Dickerson D; Ang A; Dolezal B; Cooper CB
J Subst Abuse Treat; 2015 Oct; 57():36-40. PubMed ID: 25934458
[TBL] [Abstract][Full Text] [Related]
18. Parallel Effects of Methamphetamine on Anxiety and CCL3 in Humans and a Genetic Mouse Model of High Methamphetamine Intake.
Huckans M; Wilhelm CJ; Phillips TJ; Huang ET; Hudson R; Loftis JM
Neuropsychobiology; 2017; 75(4):169-177. PubMed ID: 29402784
[TBL] [Abstract][Full Text] [Related]
19. Characterizing methamphetamine withdrawal in recently abstinent methamphetamine users: a pilot field study.
Mancino MJ; Gentry BW; Feldman Z; Mendelson J; Oliveto A
Am J Drug Alcohol Abuse; 2011 Mar; 37(2):131-6. PubMed ID: 21219261
[TBL] [Abstract][Full Text] [Related]
20. Methamphetamine-Related Disorders.
Gouzoulis-Mayfrank E; Härtel-Petri R; Hamdorf W; Havemann-Reinecke U; Mühlig S; Wodarz N
Dtsch Arztebl Int; 2017 Jun; 114(26):455-461. PubMed ID: 28705298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
